[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
For Authors::
For Reviewers::
Subscription::
News & Events::
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE

:: Volume 21, Issue 2 (4-2023) ::
Int J Radiat Res 2023, 21(2): 343-348 Back to browse issues page
Prophylactic irradiation meta-analysis in reducing procedure tract metastasis incidence in malignant pleural mesothelioma
H-F Chen , C-W Xu , W-X Wang , L-C Huang , P-E Chen , X-F Li , G. Lan , Z-Q Zhai , Y-C Zhu , K-Q Du , M-Y Fang
Department of Thoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing Zhejiang 314000, People's Republic of China , 918576941@qq.com
Abstract:   (576 Views)
Background: Malignant pleural mesothelioma (MPM) diagnoses are primarily based on pleural biopsy. Invasive procedures may result in iatrogenic dissemination of tumor cells along the subcutaneous channels. The purpose of our study was to clarify the effect of prophylactic radiotherapy on the incidence of metastasis in patients afflicted with MPM. Materials and Methods: Relevant studies were searched in PubMed, Cochrane Library, and Embase databases from the establishment of the library to February 2022. The quality of the included studies was evaluated, and the data were statistically analyzed. Results: Seven articles were obtained, and 1030 patients were included in the study, which allowed comparison of the procedure to track metastases (PTMs) incidences between radiotherapy and control groups. The results revealed statistically significant differences in the incidence of PTMs between the two groups (OR=0.48, 95% confidence interval [CI]:0.33, 0.69, p<0.0001). Subgroup analysis further showed that preventive radiotherapy could effectively reduce the incidence of PTMs in MPM patients who underwent large-caliber invasive procedures but could not reduce the incidence of PTMs after small-caliber invasive procedures. Prophylactic radiotherapy in patients with epithelial PTM types could reduce the incidence (OR=0.27, 95% CI:0.11, 0.69, P=0.006). Conclusion: Prophylactic radiotherapy is safe and can effectively prevent the occurrence of iatrogenic PTMs in patients with epithelial MPM who have undergone thoracotomy, thoracoscopy, indwelling chest wall drainage tubes, and other large-caliber operations.
Keywords: Malignant pleural mesothelioma, prophylactic irradiation, procedure tract metastases.
Full-Text [PDF 804 kb]   (478 Downloads)    
Type of Study: Review article | Subject: Radiation Biology
References
1. Howlader N, et al. (2021) SEER cancer statistics review, 1975-2016. National Cancer Institute, Bethesda, MD. Available from https://seer.cancer.gov/archive/csr/1975_ 2016/ based on November 2018 SEER data submission, posted to the SEER web site, April 2019.].
2. Selikoff IJ, Hammond EC, Seidman H (1980) Latency of asbestos disease among insulation workers in the United States and Canada. Cancer, 46(12): 2736-2740. https://doi.org/10.1002/1097-0142(19801215)46:12<2736::AID-CNCR2820461233>3.0.CO;2-L [DOI:10.1002/1097-0142(19801215)46:123.0.CO;2-L]
3. Feller-Kopman DJ, Reddy CB, DeCamp MM, Diekemper RL, Gould MK,Henry T, Iyer NP, et al. (2018) Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med, 198(7): 839-849. [DOI:10.1164/rccm.201807-1415ST] [PMID]
4. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, et al. (2016) NCCN Guidelines Insights: malignant pleural mesothelioma, version 3. J Natl Compr Cane Netw , 14: 825-836. [DOI:10.6004/jnccn.2016.0087] [PMID] []
5. Popat S, Baas P, Faivre-Finn C, Girard N, Nicholson AG, Nowak AK, et al. (2015) Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 5(26): 31-39. [DOI:10.1093/annonc/mdv199] [PMID]
6. Boutin C, Rey F, Viallat JR (1995) Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest, 108(3): 754-758. [DOI:10.1378/chest.108.3.754] [PMID]
7. Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, et al. (2010) Guidelines of the european respiratory society and the european society of thoracic surgeons for the management of malignant pleural mesothelioma. Eur Respir J, 35(3): 479-495. [DOI:10.1183/09031936.00063109] [PMID]
8. Van Zandwijk N, Clarke C, Henderson D, Musk AW, Fong K, Nowak A, et al. (2013) Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis, 5(6): E254-E307.
9. Baas P, Fennell D, Kerr KM, Van Schil PE, Haas RL, Peters S (2015) Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol, 26(5): v31-V39. [DOI:10.1093/annonc/mdv199] [PMID]
10. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, et al. (2016) NCCN guidelines insights: malignant pleural mesothelioma, version 3.2016. J Compr Canc Netw, 14(7): 825-836. [DOI:10.6004/jnccn.2016.0087] [PMID] []
11. Bergamin S, Tio M, Stevens MJ (2018) Prophylactic procedure tract radiotherapy for malignant pleural mesothelioma: a systematic review and meta-analysis. Clin Transl Radiat Oncol, 13: 38-43. [DOI:10.1016/j.ctro.2018.09.004] [PMID] []
12. O'Rourke N, Garcia JC, Paul J, Lawless C, McMenemin R, Hill J (2007) A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol, 84(1): 18-22. [DOI:10.1016/j.radonc.2007.05.022] [PMID]
13. Clive AO, Taylor H, Dobson Lee, Wilson Paula, Winton E, Panakis N, et al. (2016) Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial. Lancet Oncol, 17(8): 1094-1104. [DOI:10.1016/S1470-2045(16)30095-X]
14. Bayman N, Appel W, Ashcroft L, Baldwin DR, Bates A, Darlison L, et al. (2019) Prophylactic irradiation of tracts in patients with malignant pleural mesothelioma: an open-label, multicenter, phase III randomized trial. J Clin Oncol, 37(14): 1200-1208. [DOI:10.1200/JCO.18.01678] [PMID]
15. Cellerin L, Garry P, Mahe MA, Chailleux E (2004) Malignant pleural mesothelioma: radiotherapy for the prevention of seeding nodules.Rev Mai Respir, 21(1): 53-8. [DOI:10.1016/S0761-8425(04)71235-8]
16. Chapman A, Mulrennan S, Ladd B, Muers MF (2008) Population based epidemiology and prognosis of mesothelioma in Leeds, UK. Thorax, 63(5): 435-9. [DOI:10.1136/thx.2007.081430] [PMID]
17. Froment MA, Frechette E, Dagnault A (2011) Prophylactic irradiation of intervention sites in malignant pleural mesothelioma.Radiother Oncol, 101(2): 307-10. [DOI:10.1016/j.radonc.2011.08.038] [PMID]
18. Gounant V, Brosseau S, Zalcman G (2021) Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment. Ther Adv Med Oncol, 12(10):17588359211061956. [DOI:10.1177/17588359211061956] [PMID] []
19. Davies HE, Musk AW, Lee YC (2008) Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues. Curr Opin Pulm Med, 14(4): 326-30. [DOI:10.1097/MCP.0b013e3282fcea50] [PMID]
20. Metintas M, Ak G, Parspour S, Yildirim H, Erginel S, Alatas F, et al. (2008) Local recurrence of tumor at sites of intervention in malignant pleural mesothelioma. Lung Cancer, 61(2): 255-261. [DOI:10.1016/j.lungcan.2007.12.022] [PMID]
21. Agarwal PP, Seely JM, Matzinger FR, MacRae RM, Peterson RA, Maziak DE, et al. (2006) Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy. Radiology, 241(2): 589-94. [DOI:10.1148/radiol.2412051020] [PMID]
22. Thomas R, Budgeon CA, Kuok YJ, Read C, Fysh ETH, Bydder S, et al. (2014) Catheter tract metastasis associated with indwelling pleural catheters. J Chest, 146(3): 557-562. [DOI:10.1378/chest.13-3057] [PMID]
23. Perrot M, Wu L, Wu M, Cho BC (2017) Radiotherapy for the treatment of malignant pleural mesothelioma. J Lancet Oncol, 18(9): e532-e542. [DOI:10.1016/S1470-2045(17)30459-X]
24. Davies HE, Musk AW, Lee YC (2008) Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues. Curr Opin Pulm Med, 14(4): 326-30. [DOI:10.1097/MCP.0b013e3282fcea50] [PMID]
25. Lee CC, Soon YY, Vellayappan B, Leong CN, Koh WY, Tey JCS (2021) Prophylactic irradiation of tracts in patients with malignant pleural mesothelioma: A systematic review and meta-analysis of randomized trials. Crit Rev Oncol Hematol, 160: 103278. [DOI:10.1016/j.critrevonc.2021.103278] [PMID]
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Chen H, Xu C, Wang W, Huang L, Chen P, Li X, et al . Prophylactic irradiation meta-analysis in reducing procedure tract metastasis incidence in malignant pleural mesothelioma. Int J Radiat Res 2023; 21 (2) :343-348
URL: http://ijrr.com/article-1-4777-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 21, Issue 2 (4-2023) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.05 seconds with 50 queries by YEKTAWEB 4652